Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 7, 2021Advanced ScienceOpen Access

Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

FCFan ChenPeople's Hospital of Xinjiang Uygur Autonomous RegionJLJinpeng LiuMinistry of Education of the People's Republic of ChinaRFRobert M FlightUniversity of Kentucky

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2021) studied this question.

synapsesocial.com/papers/6a2376fa0f6fe640299eca18https://doi.org/10.1002/advs.202101999
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains2015 · 281 citations
  2. 2The transcriptional landscape and mutational profile of lung adenocarcinoma2012 · 603 citations
  3. 3PI3K inhibition sensitizes EGFR wild‑type NSCLC cell lines to erlotinib chemotherapy2020 · 13 citations
  4. 4Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia2012 · 235 citations
  5. 5Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin2018 · 177 citations